Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies

Clinical trial NCT00820508 · COMPLETED

Trial details

NCT number: NCT00820508
Sponsor: Chroma Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematological Disease Lymphoid Malignancies

Start date: 2008-12-01
Primary completion: 2011-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.